Kévin Ly
Impact in
-
- Cancer, Lipids, and Metabolism
-
- Atherosclerosis and Cardiovascular Diseases
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 5
- Viral-associated cancers and disorders 2
- Co-authors
- Robert DayRoxane DesjardinsNabil G. SeidahMarie‐Claude AsselinAnnik PratGaétan MayerPeter S. McPhersonMark R. Witmer
- Journals
- Journal of Biological Chemistry (4 papers)Scientific Reports (2 papers)Science (2 papers)Journal of Medicinal Chemistry (2 papers)Blood (1 paper)
- Partner nations
- CanadaUnited StatesPoland
In The Last Decade
Kévin Ly
19 papers receiving 522 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 103
- Immunology 119
- Surgery 246
- Cell Biology 58
- Molecular Biology 218
Countries citing papers authored by Kévin Ly
This map shows the geographic impact of Kévin Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Ly more than expected).
Fields of papers citing papers by Kévin Ly
This network shows the impact of papers produced by Kévin Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Ly. The network helps show where Kévin Ly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kévin Ly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 29 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 29 | |
| 7 | 2021 | 8 | |
| 8 | 2019 | 37 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 10 | |
| 12 | 2017 | 6 | |
| 13 | 2016 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 13 | |
| 16 | 2015 | 5 | |
| 17 | 2014 | 40 | |
| 18 | 2013 | 29 | |
| 19 | 2012 | 50 | |
| 20 | 2009 | 223 |
About Kévin Ly
Kévin Ly is a scholar working on Transplantation, Oncology, Geriatrics and Gerontology, Immunology and Cancer Research, having authored 20 papers that have together received 530 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Lipoproteins and Cardiovascular Health (4 papers), Ubiquitin and proteasome pathways (4 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers), Chemical Synthesis and Analysis (2 papers), Influenza Virus Research Studies (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Cancer Research (103 citations), Immunology (119 citations), Surgery (246 citations), Cell Biology (58 citations) and Molecular Biology (218 citations). Kévin Ly has collaborated with scholars based in Canada, United States and Poland. Frequent co-authors include Robert Day, Roxane Desjardins, Nabil G. Seidah, Marie‐Claude Asselin, Annik Prat, Gaétan Mayer, Peter S. McPherson, Mark R. Witmer, Franck Duclos and Steve Poirier. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports, Science, Journal of Medicinal Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.